CA Patent

CA2722093C — Pharmaceutical compositions comprising brivaracetam

Assigned to UCB SA · Expires 2015-04-28 · 11y expired

What this patent protects

The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2722093C
Jurisdiction
CA
Classification
—
Expires
2015-04-28
Drug substance claim
No
Drug product claim
No
Assignee
UCB SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.